1,502
Participants
Start Date
February 8, 2018
Primary Completion Date
December 31, 2019
Study Completion Date
April 30, 2020
Placebo
500 patients will 2 ml of normal saline
sodium nitrite 45 mg
500 patients will receive 45 mg IV sodium nitrite
sodium nitrite 60 mg
500 patients will receive a dose of 60 mg IV sodium nitrite
Harborview Medical Center, Seattle
National Heart, Lung, and Blood Institute (NHLBI)
NIH
University of Washington
OTHER